Do Son Isomorphic Labs (Google DeepMind's subsidiary) announced its first AI-designed drug is ready for clinical trials, marking a historic milestone in AI-driven pharmaceutical development.
Isomorphic Labs (Google DeepMind's subsidiary) announced its first AI-designed drug is ready for clinical trials, marking a historic milestone in AI-driven pharmaceutical development.